New drug trial targets stubborn eczema itch and rash

NCT ID NCT07277660

Recruiting now Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

Summary

This study is testing an investigational drug called galvokimig for adults with moderate-to-severe atopic dermatitis (eczema) that hasn't responded well to standard creams. Researchers will compare several doses of the drug against a placebo to see which works best at reducing skin rash and severe itching over 16 weeks. The goal is to find a new treatment option for people struggling with this chronic skin condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atd002 21004
RECRUITING

Tachikawa-shi, Japan
Atd002 21005
RECRUITING

Sakai, Japan
Atd002 21008
RECRUITING

Sapporo, Japan
Atd002 51007
RECRUITING

Toronto, Canada
Atd002 52001
RECRUITING

Troy, Michigan, 48084, United States
Atd002 52003
RECRUITING

Miami, Florida, 33133, United States
Atd002 52004
RECRUITING

Sugar Land, Texas, 77479, United States
Atd002 52005
RECRUITING

Dallas, Texas, 75230, United States
Atd002 52007
RECRUITING

Coral Gables, Florida, 33134, United States
Atd002 52008
RECRUITING

Santa Monica, California, 90404, United States
Atd002 52009
RECRUITING

Troy, Michigan, 48084, United States
Atd002 52010
RECRUITING

Omaha, Nebraska, 68144, United States
Atd002 52011
RECRUITING

Frisco, Texas, 75034, United States
Atd002 52012
RECRUITING

New Albany, Indiana, 47150, United States
Atd002 52013
RECRUITING

Boca Raton, Florida, 33486, United States
Atd002 52014
RECRUITING

Bowling Green, Kentucky, 42104, United States
Atd002 52015
RECRUITING

Savannah, Georgia, 31419, United States
Atd002 52016
RECRUITING

Frisco, Texas, 75033, United States
Atd002 52018
RECRUITING

Wheaton, Illinois, 60189, United States
Atd002 52019
RECRUITING

Philadelphia, Pennsylvania, 19114, United States
Atd002 52020
RECRUITING

The Bronx, New York, 10455, United States

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS